Daily Stock List
Nephros, Inc. (NEPH)
Greenbackers, TopPennyStockMovers, and SmarTrend Newsletters reported earlier on Nephros, Inc. (NEPH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nephros, Inc. is a commercial stage medical device company with corporate headquarters in River Edge, New Jersey. It develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration (HDF) system for use with a hemodialysis machine for the treatment of patients with end stage renal disease. Healthcare professionals affiliated with Columbia University Medical Center/New York-Presbyterian Hospital founded Nephros to develop and commercialize a hemodiafiltration system, an alternative method to hemodialysis (HD). Founded in 1997, Nephros lists on the OTC Bulletin Board.
Nephros has extended its filtration technologies to meet the demand for liquid purification in other areas, in particular water purification. The Company’s filters, called ultrafilters, are primarily utilized in dialysis centers and hospitals for the removal of biological contaminants from water, bicarbonate concentrate, and/or blood.
Nephros filters use a proprietary hollow fiber technology. The hollow fiber design enables the filters to optimize filtration – as low as 5 nanometers; flow rate – minimal disruption; and also filter life – up to 12 months. The Company has in excess of 100 patents issued around the world based on 15 different inventions.
These are mainly geared around its expertise as a filter development enterprise, specializing in hollow fiber ultrafiltration membrane technology. Nephros provides ultrafilters for sale to customers in the Dialysis Centers - Water/Bicarbonate; Dialysis Centers – Blood; Military and Outdoor Recreation, and Commercial Facilities including Hospitals markets.
In essence, Nephros has developed its alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). The Company’s proprietary blood purification technologies enable mid-HDF to be offered to chronic renal failure patients.
In May, Nephros announced that it closed its earlier announced private placement offering for gross proceeds of approximately $1.23 million. The Company issued roughly 1.83 million shares of its common stock, and 5 year warrants to purchase approximately 0.92 million shares of common stock at $0.85 per share.
Nephros, Inc. (NEPH), closed Friday's trading session at $0.65, even for the day, on 2,000 volume with 1 trade. The average volume for the last 60 days is 7,739 and the stock's 52-week low/high is $0.4902/$1.18.
Applied Minerals, Inc. (AMNL)
Real Pennies reported previously on Applied Minerals, Inc. (AMNL), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Applied Minerals, Inc., through its ownership of the historic Dragon Mine deposit, is the foremost worldwide source of Halloysite Clay and related technology solutions. The Company markets its products under the Dragonite™ trade name. Its products address the global need for high performance, eco-friendly solutions for a variety of industrial applications. The Company serves the traditional halloysite markets for use in technical ceramics and catalytic applications. Applied Minerals has its corporate headquarters in New York City and the Company lists on the OTCQB.
Applied Minerals is the leading producer of Halloysite clay and advanced, ultra-pure natural iron oxide solutions (consisting of hematite and goethite) from its wholly-owned Dragon Mine property in Utah. Halloysite is an aluminosilicate clay. It exhibits a rare, naturally occurring hollow tubular structure. Halloysite tubes have a length in the range of 0.5 - 3.0 microns, an exterior diameter in the range of 50 - 70 nanometers, and an internal diameter (lumen) in the range of 15 - 30 nanometers.
Furthermore, Applied Minerals has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications and high-performance additives & fillers for plastic composites.
The Company’s Dragonite™ is a versatile Halloysite product grade. It has a broad spectrum of applications. Its Dragonite-XR™ product grade offers unique advantages versus other reinforcing fillers, including glass fiber, mica, wollastonite or talc. It is an advanced reinforcing filler.
Applied Minerals’ Dragonite-HP™ is a high performance additive for engineering thermoplastics used at loadings of only 1-3 percent. It provides first-rate mechanical performance and cycle time reduction. In addition, the Company’s Dragonite-PureWhite™ is the highest purity Dragonite™ product. It meets the strict specifications of the cosmetic industry.
Applied Minerals has indicated that Dragonite continues to attract considerable interest from adhesive, epoxy, and thermoset manufacturers as an all-natural, high value additive. The Company estimates the size of the worldwide adhesives market alone to be roughly 9.4 million tons annually. This presents a major volume opportunity for Dragonite even at low loading rates.
Concerning Iron Oxide products, Applied Minerals offers AMIRON. This is an advanced natural iron oxide for an array of pigmentary and technical applications. The Company launched its AMIRON line of advanced natural iron oxide pigments to the construction, wood coatings, paints, industrial coatings, plastics and rubber markets in 2014.
Recently, Applied Minerals appointed Mr. Brian Newsome as its Director of Sales. As Director of Sales, Mr. Newsome will manage the sales, distribution and marketing efforts for Applied Minerals’ different product lines. From 2012 to 2015, he was a Sales Manager at BASF Corporation, the world's leading chemical company. While at BASF, he concentrated on the sale of specialty kaolin to the paint, coatings, plastics and rubber markets in the Southern and Western United States.
Applied Minerals, Inc. (AMNL), closed Friday's trading session at $0.49, down 2.00%, on 10,275 volume with 5 trades. The average volume for the last 60 days is 42,374 and the stock's 52-week low/high is $0.3622/$0.835.
Premier Biomedical, Inc. (BIEI)
PennyStocks24, Information Solutions Group, and FeedBlitz reported previously on Premier Biomedical, Inc. (BIEI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
OTC BB-listed Premier Biomedical, Inc. is a research-based medical development company. Its goal is to discover and develop medical treatments, in collaboration with the University of Texas at El Paso (UTEP) and the US Department of Defense, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier Biomedical is headquartered in El Paso, Texas and also has offices in Pennsylvania.
The Company is a medical development enterprise specializing in breakthroughs for serious illnesses. It has licensed the technology behind many provisional patents in the U.S. and a PCT Europe National Patent in the areas of Cancer, Sepsis, and Multiple Sclerosis. It has developed an aggressive timetable to further the development of these technologies through the laboratory, hospital, and clinical trials. It has commenced the development of potential patient trial application lists.
Premier Biomedical is initially targeting the treatment of Alzheimer's disease, Traumatic Brain Injury, and Cancer. The Company announced in June 2014 that the United States Patent Office approved a patent on the Company’s proprietary medication Feldetrex ™. The design of this medication is to relieve the symptoms of neuropathic pain and fibromyalgia.
Premier Biomedical has been evaluating strategies to take its own Anti-CTLA4 breast cancer treatment through the Food and Drug Administration (FDA) approval process.
The Company has a number of other continuing projects, in addition to its Anti-CTLA-4-based breast cancer drug. In two upcoming clinical trials, its plan is to test its Feldetrex™ pain medication, followed by a separate clinical trial of its core technology designed to remove the pathophysiological basis of the disease.
Premier Biomedical has signed a Patent License Agreement with the University of Texas El Paso (UTEP), covering the cancer treatment process called "CD152-LDMC" that the two entities have been developing in cooperation at the Border Biomedical Research Center, located in UTEP's $45-million Bioscience Research Building. The proprietary process strives to block a molecule called cytotoxic T-lymphocyte antigen or CTLA-4, through combining CTLA-4 blocking antibody CD152, along with Low Dose Metronomic Chemotherapy. Significant progress has been made over the past year advancing the development of CD152-LDMC.
Recently, Premier Biomedical announced that its sponsored partner in R&D, the University of Texas at El Paso (UTEP), has developed a unique antibody against three immune suppressors, CTLA-4, PD1, and BTLA. A Provisional Patent Application on this antibody family was filed early in May 2015. Premier Biomedical is planning to start an application for attaining approval by the FDA for utilization of the compound as a major cancer immunotherapy drug.
Premier Biomedical, Inc. (BIEI), closed Friday's trading session at $0.0502, down 28.29%, on 1,100 volume with 2 trades. The average volume for the last 60 days is 14,381 and the stock's 52-week low/high is $0.0549/$0.36.
BreedIT Corp. (BRDT)
SmallCapVoice and PennyStocks Forever reported previously on BreedIT Corp. (BRDT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
BreedIT Corp., via its Israeli subsidiary, BreedIT Ltd., is the developer of highly sophisticated agro-breeding solutions for plant breeders and researchers. The Company’s proven iBreedIT® - the Intelligent Decision Support System (IDSS) for breeders was developed by a team consisting of among the world's foremost breeding specialists for optimizing the breeding processes. iBreedIT® services the plant breeding needs of corporations, research, as well as government institutions.
Founded in 2013, BreedIT has offices in New York, New York, and Rehovot, Israel. The Company’s shares trade on the OTC Markets’ OTCQB. The Company was previously known as Progaming Platforms Corp. It changed its name to BreedIT Corp. in November of 2013.
BreedIT’s above-mentioned IDSS provides advanced solutions for generating and disseminating knowledge. This is targeted at helping breeders to plan, manage, and analyze their breeding data and to perform research activities quickly and effectively. Breeders can buy a SaaS (Software as a Service) license for the proprietary iBreedIT platform.
BreedIT is a leading provider of software designed to assist breeders in modifying crops to emphasize specific traits. By way of its subsidiary BreedIT Ltd., it has teamed up with Seach Ltd. - one of only eight entities licensed to grow and distribute medical cannabis in Israel - to form KanaboSeed.
KanaboSeed works to discover, develop, and also commercialize new cannabis strains for the management of a variety of diseases and conditions. Seach Ltd. will initially be growing the KanaboSeed strains. However, the long-term plan for the business model comes from possible license agreements with medical cannabis growers interested in the proprietary genetics.
This past January, BreedIT, through its Israeli subsidiary, BreedIT Ltd., announced that it entered into a pilot agreement for its BreedIT Mobile™ with Vilmorin & Cie. BreedIT Ltd. will integrate the mobile platform to work with the Synergene Seed systems already being used by Vilmorin's Ha'zera and HM-Clause business units.
The BreedIT Mobile™ enables breeders to utilize tablets and smartphones to collect plant phenotypes and other information vital to the breeding process. The BreedIT Mobile™ is a cloud-based service and mobile application. The design of it is to help breeders and growers be more efficient in the field and other remote locations.
BreedIT Corp. (BRDT), closed Friday's trading session at $0.023, up 4.55%, on 14,850 volume with 5 trades. The average volume for the last 60 days is 82,182 and the stock's 52-week low/high is $0.015/$0.355.
Eastside Distilling, Inc. (ESDI)
SmallCapVoice reported earlier on Eastside Distilling, Inc. (ESDI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Eastside Distilling, Inc. is a producer of award-winning master-crafted spirits. All of the Company’s spirits are master crafted from natural ingredients. The Company has been producing high-quality, master crafted spirits since 2008. Eastside Distilling’s shares trade on the OTC Markets Group’s OTCQB. Based in Portland, Oregon, Eastside Distilling is located in Southeast Portland's Distillery Row.
Eastside Distilling’s comprehensive line of spirits include the award-winning Burnside Bourbon and Burnside 'Oregon Oaked' Bourbon, and also the award-winning flavored whiskeys, Marionberry and Cherry Bomb. The Company is distinguished by its highly decorated product line-up that includes the aforementioned, as well as Below Deck Rums, Portland Potato Vodka and a distinct line of infused whiskeys. Eastside Distilling also produces small batch and seasonal products, which include Holiday Spiced Liqueur and new Peppermint Bark and Egg Nog Liqueurs.
Earlier this month, Eastside Distilling announced that it was granted a seller's permit by the New York State Liquor Authority. This opens doors to one of the top five liquor consumption states in the U.S. New York also now becomes the eighth state where Eastside Distilling is actively distributing, following the entrance of Virginia in June 2015.
This week, Eastside Distilling announced that it launched two new American Whiskeys, Barrel Hitch American Whiskey and Barrel Hitch 'Oregon Oak' American Whiskey. The Company’s Master Distiller, Melissa Heim, and its Chief Branding Officer, Carrie Earles, worked together to create the Barrel Hitch brand with one objective in mind: make a premium American whiskey enjoyable by all.
Barrel Hitch American Whiskey is bottled at 80 proof. Barrel Hitch 'Oregon Oak' American Whiskey takes its Barrel Hitch American Whiskey through a second "Oregon Oaked" aging process for an additional four months. Barrel Hitch 'Oregon Oak' American Whiskey is bottled at 88 proof.
The Company’s new American whiskeys have received listing approval by the Oregon Liquor Control Commission. Eastside Distilling is preparing initial shipments for distribution to Oregon's state-run liquor stores, with the rollout to other states planned to follow shortly.
Eastside Distilling, Inc. (ESDI), closed Friday's trading session at $2.00, up 11.11%, on 67,997 volume with 38 trades. The average volume for the last 60 days is 43,917 and the stock's 52-week low/high is $0.40/$5.00.
On the Move Systems, Inc. (OMVS)
The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.83, up 112.82%, on 62,596 volume with 87 trades. The stock’s average daily volume over the past 60 days is 19,902, and its 52-week low/high is $0.2501/$11.04.
On the Move Systems, Inc. (OMVS) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.
Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.
OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.
In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer
On the Move Systems, Inc. Company Blog
On the Move Systems, Inc. News:
OMVS: Shared Economy Courier Service Offers Great Market Potential
Noted Shared Economy Survey Results Bolster OMVS Courier Service Plans
OMVS Exploring Creation of Uber-Style Shared Economy Courier Service
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $2.29, up 15.08%, on 20,307 volume with 65 trades. The stock’s average daily volume over the past 60 days is 2,612, and its 52-week low/high is $0.51/$6.00.
The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.
Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.
To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.
ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Initiates Production on Bag-in-Box Vodka Packaging
ASCC Adds Second Country to Distribution Network
ASCC: RWB Vodka Reaches New Brand Milestone
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0039, up 12.07%, on 5,728,062 volume with 51 trades. The stock’s average daily volume over the past 60 days is 10,498,708, and its 52-week low/high is $0.0008/$0.034.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
The One World Doll Project Announces New Orders from Amazon.com
One World Holdings, Inc. to File 8k Answering Shareholder Questions About Company Share Structure
New York Daily News Releases Feature Story on the Prettie Girls Tween Scene Dolls and the One World Doll Project
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0432, up 3.35%, on 345,800 volume with 16 trades. The stock’s average daily volume over the past 60 days is 309,820, and its 52-week low/high is $0.0404/$0.128.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting
International Stem Cell Corporation Announces 2015 First Quarter Results
International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation
View Systems, Inc. (VSYM)
The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.0041, up 13.89%, on 1,909,714 volume with 29 trades. The stock’s average daily volume over the past 60 days is 538,498, and its 52-week low/high is $0.0036/$0.024.
View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.
The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.
The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.
Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer
View Systems, Inc. Company Blog
View Systems, Inc. News:
View Systems, Inc. Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
View Systems Continues to Install Its Proprietary Scanning Systems Nationwide
View Systems, Inc. (VSYM) Announces Engagement of QualityStocks Investor Relations Services
Today's Top 3
Fortune Stock Alerts
INO.com Market Report
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Aristocrat Group Corp. (ASCC) Initiates Production on Bag-in-Box Vodka Packaging
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) to Engage With Shareholders and Investors via Conference Call
- Fastfunds Financial Corp. (FFFC) Subsidiary Pure Grow Systems, LLC Announces Product Label Approval
- Galenfeha, Inc. (GLFH) Products Offered by Leading Power and Automation Company
- Giggles N' Hugs, Inc. (GIGL) CEO Featured in Exclusive QualityStocks Interview
- Growblox Sciences, Inc. (GBLX) is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
- International Stem Cell Corp. (ISCO) to Present at International Society for Cellular Therapy Annual Meeting
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- On the Move Systems, Inc. (OMVS) Shared Economy Courier Service Offers Great Market Potential
- One World Holdings, Inc. (OWOO) The One World Doll Project Announces New Orders from Amazon.com
- View Systems, Inc. (VSYM) Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- Wisdom Homes of America, Inc. (WOFA) Announces Engagement of QualityStocks Investor Relations Services
- WRIT Media Group, Inc. (WRIT) Featured in Exclusive QualityStocks Production Video